Larvol Delta - Phase-3-Clinical-Trial-Perioperative-Use-of-Nonacog-Gamma-a-Recombinant-Factor-IX-in-Previously-Treated-Patients-With-ModerateSevere-Hemophilia-B

Rixubis (nonacog gamma) - Baxter Healthcare, Takeda

http://www.ncbi.nlm.nih.gov/pubmed/32816519

Aug 22, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next